๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Amoxicillin - Medicines in Ireland

36 authorised products containing Amoxicillin, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 36 authorised medicines
MedicineActive substanceLicence holderStatus
Amoclav 250mg/125mg Film-coated Tablets
PA0711/162/002
Amoxicillin, Clavulanic acid Rowex Limited, Not marketed
Amoclav 500mg/125mg Film-coated tablets
PA0711/162/003
Clavulanic acid, Amoxicillin Rowex Limited, Marketed
Amoxicillin 125 mg/5 ml powder for oral suspension
PA0126/282/003
Amoxicillin Clonmel Healthcare Ltd Not marketed
Amoxicillin 250 mg hard capsules
PA0126/282/001
Amoxicillin Clonmel Healthcare Ltd Marketed
Amoxicillin 250 mg/5 ml powder for oral suspension
PA0126/282/004
Amoxicillin Clonmel Healthcare Ltd Marketed
Amoxicillin 500 mg hard capsules
PA0126/282/002
Amoxicillin Clonmel Healthcare Ltd Marketed
Amoxicillin Delbert 500 mg powder for solution for injection or infusion
PA23217/001/001
Amoxicillin Laboratoires DELBERT Marketed
Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets
PA1347/044/001
Amoxicillin, Clavulanic acid KRKA, d.d., Novo mesto Not marketed
Augmentin 250 mg/125 mg film-coated tablets
PA1077/093/007
Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 500 mg/125 mg film-coated tablets
PA1077/019/003
Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 875 mg/125 mg film-coated tablets
PA1077/019/005
Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 875 mg/125 mg film-coated tablets
PPA1463/242/001
Amoxicillin, Clavulanic acid IMED Healthcare Ltd., โ€”
Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension
PA1077/019/006
Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
PA1077/093/004
Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Clavamel Forte 500mg/125mg film-coated tablet
PA0126/243/001
Amoxicillin, Clavulanic acid Clonmel Healthcare Ltd Marketed
Co-amoxiclav 1000 mg/200 mg powder for solution for injection/infusion
PA2220/002/002
Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Marketed
Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion
PA2059/026/001
Amoxicillin, Clavulanic acid Fresenius Kabi Deutschland GmbH Marketed
Co-amoxiclav 2000 mg/200 mg powder for solution for infusion
PA2220/002/003
Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Not marketed
Co-amoxiclav 250mg/125mg Film-coated tablets
PA23148/004/001
Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav 500 mg/100 mg powder for solution for injection/infusion
PA2220/002/001
Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Marketed
Co-amoxiclav 500mg/125mg Film-coated tablets
PA23148/004/002
Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav 875mg/125mg Film-coated Tablets
PA23148/004/003
Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav Sugar Free 200 mg/28.5 mg/5 ml Powder for Oral Suspension
PA23148/005/001
Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension
PA23148/005/002
Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-Amoxiclav TEVA 1000 mg/200 mg Powder for Solution for Injection/Infusion
PA0749/011/002
Amoxicillin, Clavulanic acid Teva Pharma B.V. Marketed
Co-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/Infusion
PA0749/011/001
Amoxicillin, Clavulanic acid Teva Pharma B.V. Marketed
Germentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
PA23266/015/002
Clavulanic acid, Amoxicillin Viatris Limited Marketed
Germentin 250 mg/125 mg Film-coated Tablets
PA23266/015/003
Amoxicillin, Clavulanic acid Viatris Limited Marketed
Oramox 125 mg/5 ml powder for oral suspension
PA1418/013/001
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg hard capsules
PA1418/013/003
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg/5 ml powder for oral suspension
PA1418/013/002
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 500 mg hard capsules
PA1418/013/004
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Pinamox 125 mg/5 ml powder for oral suspension
PA0298/010/001
Amoxicillin Athlone Laboratories Ltd Not marketed
Pinamox 250 mg hard capsules
PA0298/010/003
Amoxicillin Athlone Laboratories Ltd Not marketed
Pinamox 250 mg/5 ml powder for oral suspension
PA0298/010/002
Amoxicillin Athlone Laboratories Ltd Marketed
Pinamox 500 mg hard capsules
PA0298/010/004
Amoxicillin Athlone Laboratories Ltd Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.